Trademark: 88960200
Status Date
Tuesday, October 26, 2021
Registration Number
6533457
Registration Date
Tuesday, October 26, 2021
Filing Date
Thursday, June 11, 2020
Published for Opposition
Tuesday, August 10, 2021
5 Diagnostic testing materials in the nature of reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in diagnostic tests for medical purposes
9 Downloadable computer software for use in relation to medicine and pharmaceutical research and development services for data management, data analysis, data manipulation; downloadable computer software used to connect laboratory networks and diagnostic and pharmaceutical companies; downloadable computer software used to analyse data in the field of medicine and pharmaceutical testing, research and development; downloadable computer software for use in relation to business networking and content management in the field of medicine and pharmaceutical testing, research and development; downloadable computer software applications for data management and visualisation, for generating reports, charts and dashboards in the field of medicine and pharmaceutical research and development
42 Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing services, namely, computer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; design and development of computer databases; software design services relating to data processing test tools; provision of information and data relating to medical and veterinary research and development; technical data analysis services, namely, data analysis for medicine and pharmaceutical testing, research and development purposes; information, advice and consultancy in relation to all the aforesaid services, namely, providing information in the field of research and development of pharmaceutical preparations; Software as a service (SAAS) services featuring software in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Software as a service (SAAS) services featuring software in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Software as a service (SAAS) services featuring software in relation to data management and visualisation, for generating reports, charts and dashboards; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Platform as a service (PAAS) featuring computer software platforms for use in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management and visualisation for generating reports, charts and dashboards; information, advice and consultancy in relation to all the aforesaid services
Oct 26, 2021
Registered-Principal Register
Aug 10, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 10, 2021
Published For Opposition
Jul 21, 2021
Notification Of Notice Of Publication E-Mailed
Jul 7, 2021
Law Office Publication Review Completed
Jul 7, 2021
Approved For Pub - Principal Register
Jun 24, 2021
Teas/Email Correspondence Entered
Jun 24, 2021
Correspondence Received In Law Office
Jun 24, 2021
Assigned To Lie
Apr 12, 2021
Teas Response To Office Action Received
Mar 18, 2021
Notification Of Examiner's Amendment/Priority Action E-Mailed
Mar 18, 2021
Examiner's Amendment/Priority Action E-Mailed
Mar 18, 2021
Combined Examiner's Amendment/Priority Action Automatic Entry
Mar 18, 2021
Examiners Amendment And/Or Priority Action - Completed
Sep 21, 2020
Notification Of Non-Final Action E-Mailed
Sep 21, 2020
Non-Final Action E-Mailed
Sep 21, 2020
Non-Final Action Written
Sep 14, 2020
Assigned To Examiner
Aug 5, 2020
Assignment Of Ownership Not Updated Automatically
Jul 8, 2020
New Application Office Supplied Data Entered In Tram
Jun 15, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
